Literature DB >> 22417958

Emergency department risk stratification in upper gastrointestinal bleeding.

Huma Ali1, Eddy Lang, Alan Barkan.   

Abstract

CLINICAL QUESTION: What clinical features, compiled as a risk stratification tool, identify patients with upper gastrointestinal bleeding that can be safely managed and investigated in an outpatient setting? ARTICLE CHOSEN: Stanley AJ, Ashley D, Dalton HR. Outpatient management of patients with low-risk upper-gastrointestinal hemorrhage: multicentre validation and prospective evaluation. Lancet 2009;373:42-7.
OBJECTIVE: To validate the Glasgow-Blatchford Bleeding Score, a risk stratification tool for upper gastrointestinal bleeding.

Entities:  

Year:  2012        PMID: 22417958     DOI: 10.2310/8000.2011.110345

Source DB:  PubMed          Journal:  CJEM        ISSN: 1481-8035            Impact factor:   2.410


  4 in total

1.  Rockall score in predicting outcomes of elderly patients with acute upper gastrointestinal bleeding.

Authors:  Chang-Yuan Wang; Jian Qin; Jing Wang; Chang-Yi Sun; Tao Cao; Dan-Dan Zhu
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

Review 2.  The effectiveness of Glasgow-Blatchford Score in early risk assessment of hemodialysis patients.

Authors:  Dilay Satılmış; Burcu Genc Yavuz; Oya Güven; Ramazan Güven; Başar Cander
Journal:  Intern Emerg Med       Date:  2021-10-15       Impact factor: 3.397

3.  Validity of modified early warning, Glasgow Blatchford, and pre-endoscopic Rockall scores in predicting prognosis of patients presenting to emergency department with upper gastrointestinal bleeding.

Authors:  Seyran Bozkurt; Ataman Köse; Engin Deniz Arslan; Semra Erdoğan; Enver Üçbilek; İbrahim Çevik; Cüneyt Ayrık; Orhan Sezgin
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2015-12-30       Impact factor: 2.953

4.  Comparison of four scoring systems for risk stratification of upper gastrointestinal bleeding.

Authors:  Hakan Tuncer; Turker Yardan; Hizir Ufuk Akdemir; Talat Ayyildiz
Journal:  Pak J Med Sci       Date:  2018 May-Jun       Impact factor: 1.088

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.